Comparing methods of naloxone administration : A narrative review
The effectiveness and safety of naloxone for the reversal of opioid toxicity are reviewed. A literature search was performed using PubMed, the Cochrane Library, CINAHL, and Medline. Clinical trials comparing either the clinical efficacy or pharmacokinetic/pharmacodynamic properties displayed by intravenous, intramuscular, intranasal, subcutaneous, and nebulized naloxone were included; however, trials with primary endpoints evaluating oral or endotracheal naloxone were excluded. Naloxone was shown to be clinically effective via all routes of administration, when compared to either baseline or control. The inconsistencies in data regarding the relative outcome comparisons between administration methods were likely due to differences in concentrations of naloxone preparations and method of administration for the same route of delivery between different studies. Choice of route depends on the environment in which the opioid toxicity occurs, individual patient characteristics, and provider preference.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Journal of opioid management - 13(2017), 4 vom: 27. Juli, Seite 253-260 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fellows, Shawn E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
36B82AMQ7N |
|---|
| Anmerkungen: |
Date Completed 10.04.2018 Date Revised 10.04.2018 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.5055/jom.2017.0393 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM276233069 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM276233069 | ||
| 003 | DE-627 | ||
| 005 | 20231225011535.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5055/jom.2017.0393 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0920.xml |
| 035 | |a (DE-627)NLM276233069 | ||
| 035 | |a (NLM)28953317 | ||
| 035 | |a (PII)jom.2017.0393 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fellows, Shawn E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Comparing methods of naloxone administration |b A narrative review |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.04.2018 | ||
| 500 | |a Date Revised 10.04.2018 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The effectiveness and safety of naloxone for the reversal of opioid toxicity are reviewed. A literature search was performed using PubMed, the Cochrane Library, CINAHL, and Medline. Clinical trials comparing either the clinical efficacy or pharmacokinetic/pharmacodynamic properties displayed by intravenous, intramuscular, intranasal, subcutaneous, and nebulized naloxone were included; however, trials with primary endpoints evaluating oral or endotracheal naloxone were excluded. Naloxone was shown to be clinically effective via all routes of administration, when compared to either baseline or control. The inconsistencies in data regarding the relative outcome comparisons between administration methods were likely due to differences in concentrations of naloxone preparations and method of administration for the same route of delivery between different studies. Choice of route depends on the environment in which the opioid toxicity occurs, individual patient characteristics, and provider preference | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Analgesics, Opioid |2 NLM | |
| 650 | 7 | |a Narcotic Antagonists |2 NLM | |
| 650 | 7 | |a Naloxone |2 NLM | |
| 650 | 7 | |a 36B82AMQ7N |2 NLM | |
| 700 | 1 | |a Coppola, Alexander J |e verfasserin |4 aut | |
| 700 | 1 | |a Gandhi, Mona A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of opioid management |d 2005 |g 13(2017), 4 vom: 27. Juli, Seite 253-260 |w (DE-627)NLM168553171 |x 1551-7489 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2017 |g number:4 |g day:27 |g month:07 |g pages:253-260 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5055/jom.2017.0393 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2017 |e 4 |b 27 |c 07 |h 253-260 | ||